Tandem Diabetes Care, Inc. (TNDM)
20.42
-0.14
(-0.68%)
USD |
NASDAQ |
Sep 03, 16:00
20.42
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Investing (Quarterly) : -87.34M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.34M |
| March 31, 2026 | -195.45M |
| December 31, 2025 | -14.98M |
| September 30, 2025 | 20.54M |
| June 30, 2025 | 58.13M |
| March 31, 2025 | 9.186M |
| December 31, 2024 | 5.01M |
| September 30, 2024 | -19.90M |
| June 30, 2024 | -3.54M |
| March 31, 2024 | -5.056M |
| December 31, 2023 | -16.58M |
| September 30, 2023 | -48.52M |
| June 30, 2023 | 5.698M |
| March 31, 2023 | -26.33M |
| December 31, 2022 | 35.78M |
| September 30, 2022 | -14.16M |
| June 30, 2022 | 6.357M |
| March 31, 2022 | 5.197M |
| December 31, 2021 | -76.82M |
| September 30, 2021 | -39.20M |
| June 30, 2021 | -64.76M |
| March 31, 2021 | -6.094M |
| December 31, 2020 | -59.63M |
| September 30, 2020 | -137.82M |
| June 30, 2020 | -131.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.92M |
| December 31, 2019 | -20.90M |
| September 30, 2019 | -22.17M |
| June 30, 2019 | -14.66M |
| March 31, 2019 | 0.778M |
| December 31, 2018 | -6.591M |
| September 30, 2018 | -46.81M |
| June 30, 2018 | -27.82M |
| March 31, 2018 | -9.514M |
| December 31, 2017 | -1.419M |
| September 30, 2017 | -0.244M |
| June 30, 2017 | 1.838M |
| March 31, 2017 | 2.607M |
| December 31, 2016 | 4.575M |
| September 30, 2016 | 5.828M |
| June 30, 2016 | 1.681M |
| March 31, 2016 | -1.636M |
| December 31, 2015 | 8.86M |
| September 30, 2015 | 11.53M |
| June 30, 2015 | 0.305M |
| March 31, 2015 | -18.27M |
| December 31, 2014 | 9.109M |
| September 30, 2014 | -15.15M |
| June 30, 2014 | 1.194M |
| March 31, 2014 | -30.63M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DexCom, Inc. | 329.80M |
| Modular Medical, Inc. | -0.688M |
| Senseonics Holdings, Inc. | -63.38M |
| NeuroPace, Inc. | -0.125M |
| Abbott Laboratories | -673.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.63M |
| Cash from Financing (Quarterly) | 2.154M |
| Free Cash Flow | -26.62M |
| Free Cash Flow Per Share (Quarterly) | -0.5605 |
| Free Cash Flow to Equity (Quarterly) | -43.20M |
| Free Cash Flow to Firm (Quarterly) | -36.17M |
| Free Cash Flow Yield | -1.91% |